ArticleCardiovascular diabetology2024

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.

Stephen J Nicholls et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.